U.S. indexes are pointed lower this morning, as traders await comments from Fed Chair Janet Yellen -- which many expect will underscore expectations for a rate hike this month, especially in light of today's positive ADP report. Among the equities in focus are social media giant Facebook Inc (NASDAQ:FB), Internet interest Yahoo! Inc. (NASDAQ:YHOO), and drugmaker Zafgen Inc (NASDAQ:ZFGN).
ZFGN is headed for a sharp 58% plunge from its Tuesday close of $15.93, which will mean a new all-time low. The drop comes as the drugmaker reported a second death in an ongoing trial of a treatment for a rare genetic disorder that is linked to obesity. After Zafgen Inc reported the first patient death in October, the U.S. Food and Drug Administration (FDA) placed a partial hold on the study, while the shares dropped to an all-time low of $9.53. ZFGN is now working with the FDA to determine what steps to take next. Meanwhile, five of the six brokerages following the stock -- which has shed nearly half its value year-to-date -- maintain a "buy" rating or better. Any downgrades could exacerbate selling pressure.
Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!
